Phase II study of OSI-211 (liposomal lurtotecan) in...

Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck: An EORTC New Drug Development Group Study

F. Duffaud, M. Borner, P. Chollet, J.B. Vermorken, J. Bloch, M. Degardin, F. Rolland, C. Dittrich, B. Baron, D. Lacombe, P. Fumoleau
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
40
Year:
2004
Language:
english
Pages:
2753
DOI:
10.1016/j.ejca.2004.08.024
File:
PDF, 248 KB
english, 2004
Conversion to is in progress
Conversion to is failed